<!DOCTYPE html><html xml:lang="en" lang="en" xmlns="http://www.w3c.org/1999/xhtml">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <title>HEPBD_J</title>
    <meta name="title" content="NHANES 2017-2018: Hepatitis B: Core antibody, Surface antigen, and Hepatitis D antibody  Data Documentation, Codebook, and Frequencies" />
    <link rel="stylesheet" href="https://wwwn.cdc.gov/nchs/nhanes/css/documentation.css" />
  </head>
  <body class="nhanes-doc">
    <div id="toc">
      <h3>Table of Contents</h3>
      <div id="toc-scroll">
        <ul>
          <li>
            <a href="#Component_Description">Component Description</a>
          </li>
          <li>
            <a href="#Eligible_Sample">Eligible Sample</a>
          </li>
          <li>
            <a href="#Description_of_Laboratory_Methodology">Description of Laboratory Methodology</a>
          </li>
          <li>
            <a href="#Laboratory_Method_Files">Laboratory Method Files</a>
          </li>
          <li>
            <a href="#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</a>
          </li>
          <li>
            <a href="#Data_Processing_and_Editing">Data Processing and Editing</a>
          </li>
          <li>
            <a href="#Analytic_Notes">Analytic Notes</a>
          </li>
          <li>
            <a href="#Codebook">Codebook</a>
            <ul id="CodebookLinks">
              <li>
                <a href="#SEQN">SEQN - Respondent sequence number</a>
              </li>
              <li>
                <a href="#LBXHBC">LBXHBC - Hepatitis B core antibody</a>
              </li>
              <li>
                <a href="#LBDHBG">LBDHBG - Hepatitis B surface antigen</a>
              </li>
              <li>
                <a href="#LBDHD">LBDHD - Hepatitis D antibody (anti-HDV)</a>
              </li>
            </ul>
          </li>
        </ul>
      </div>
    </div>
    <div id="wrapper">
      <div id="PageHeader">
        <h1>National Health and Nutrition Examination Survey</h1>
        <h2>2017-2018 Data Documentation, Codebook, and Frequencies</h2>
        <h3>Hepatitis B: Core antibody, Surface antigen, and Hepatitis D antibody  (HEPBD_J)</h3>
        <h4> Data File: HEPBD_J.xpt</h4>
        <h5 class="left">First Published: February 2020</h5>
        <h5 class="right">Last Revised: May 2022</h5>
      </div>
      <div id="Sections">
        <h2 id="Component_Description">Component Description</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Hepatitis viruses
constitute a major public health problem because of the morbidity and mortality
associated with the acute and chronic consequences of these infections. Co-infection
with hepatitis D virus (HDV) in persons with acute or chronic hepatitis B virus
(HBV) infection can lead to fulminant hepatitis. New immunization strategies
have been developed to eliminate the spread of HBV and hepatitis A virus (HAV)
in the United States. Recommendations have also been developed for the
prevention and control of hepatitis C virus (HCV) infection. Because of the
high rate of asymptomatic infection with these viruses, information about the
prevalence of these diseases is needed to monitor prevention efforts. By
testing a nationally representative sample of the U.S. population, NHANES will
provide the most reliable estimates of age-specific prevalence needed to
evaluate the effectiveness of the strategies to prevent these infections. In
addition, NHANES provides the means to better define the epidemiology of other
hepatitis viruses. NHANES testing for markers of infection with hepatitis
viruses will be used to determine secular trends in infection rates across most
age and racial/ethnic groups, and will provide a national picture of the
epidemiologic determinants of these infections.</p><h2 id="Eligible_Sample">Eligible Sample</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Examined
participants aged 6 years or older were eligible.</p><h2 id="Description_of_Laboratory_Methodology">Description of Laboratory Methodology</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Hepatitis B core
antibody (anti-HBc)</b> </p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The VITROS
Anti-HBc assay is performed using the VITROS Anti-HBc Reagent Pack and VITROS
Immunodiagnostic Products Anti-HBc Calibrator on the VITROS ECi/ECiQ or VITROS
3600 Immunodiagnostic System.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">A competitive
immunoassay technique is used. This involves the reaction of anti-HBc in the
sample with hepatitis B core antigen (HBcAg) coated wells. Unbound sample is
removed by washing. Horseradish peroxidase (HRP)-labeled antibody conjugate
(mouse monoclonal anti-HBc) is then allowed to react with the remaining exposed
HBcAg on the well surface. Unbound conjugate is removed by washing. <br />
<br />
The bound HRP conjugate is measured by a luminescent reaction. A reagent
containing luminogenic substrates (a luminol derivative and a peracid salt) and
an electron transfer agent is added to the wells. The HRP in the bound
conjugate catalyzes the oxidation of the luminol derivative, producing light.
The electron transfer agent (a substituted acetanilide) increases the level of
light produced and prolongs its emission. The light signals are read by the
system. The amount of HRP conjugate bound is indicative of the concentration of
anti HBc present.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Hepatitis B
surface antigen (HBsAg)</b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The VITROS HBsAg
test is performed using the VITROS HBsAg Reagent Pack and VITROS Immunodiagnostic
Products HBsAg Calibrator on the VITROS ECi/ECiQ Immunodiagnostic Systems and
the VITROS 3600 Immunodiagnostic System. An immunometric immunoassay technique
is used, which involves the simultaneous reaction of HBsAg in the sample with
mouse monoclonal anti-HBs antibody coated onto the wells and a horseradish
peroxidase (HRP)-labeled mouse monoclonal anti-HBs antibody in the conjugate.
Unbound conjugate is removed by washing.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The bound HRP
conjugate is measured by a luminescent reaction. A reagent containing
luminogenic substrates (a luminol derivative and a peracid salt) and an
electron transfer agent is added to the wells. The HRP in the bound conjugate
catalyzes the oxidation of the luminol derivative, producing light. The
electron transfer agent (a substituted acetanilide) increases the level of
light produced and prolongs its emission. The light signals are read by the
system. The amount of HRP conjugate bound is indicative of the level of HBsAg
present in the sample.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Hepatitis D
antibody (anti-HDV) <br />
</b><br />
The method for qualitative anti-HD determination is a simultaneous competitive
assay. Anti-HD present in the sample and labeled anti-HD antibodies complete
for a fixed quantity of HDAg bound to the solid phase. The quantity of enzyme
tracer bound to the solid phase and consequently the enzyme activity are
inversely proportional to the anti-HD concentration present in samples or
controls. <br />
<br />
Enzyme activity is measured by adding a colorless chromogen/substrate solution.
The enzyme action on the chromogen/substrate produces a color, which is
measured with a photometer.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Refer to the
Laboratory Method Files section for a detailed description of the laboratory
methods used.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">There were no
changes to the lab method, lab equipment, or lab site for this component in the
NHANES 2017-2018 cycle. </p><h2 id="Laboratory_Method_Files">Laboratory Method Files</h2>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/public/2017/labmethods/HEPBD-J-MET-HEPATITIS-B-CORE-ANTIBODY-508.pdf">Hepatitis B Core Antibody</a>
          <span> (February 2020)</span>
        </p>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/public/2017/labmethods/HEPBD-J-MET-HEPATITIS-B-SURFACE-ANTIGEN-508.pdf">Hepatitis B Surface Antigen</a>
          <span> (February 2020)</span>
        </p>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/public/2017/labmethods/HEPBD-J-MET-HEPATITIS-D-ANTIBODY-508.pdf">Hepatitis D Antibody</a>
          <span> (February 2020)</span>
        </p>
        <h2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Serum samples were
processed, stored, and shipped to the Division of Viral Hepatitis, National
Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for
Disease Control and Prevention, Atlanta, GA for analysis.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Detailed
instructions on specimen collection and processing are discussed in the NHANES <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2017-2018/manuals/2017_MEC_Laboratory_Procedures_Manual.pdf">Laboratory
Procedures Manual (LPM)</a>. Vials were
stored under appropriate frozen (&ndash;30&deg;C) conditions until they were shipped to
Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention for testing. </p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The NHANES quality
assurance and quality control (QA/QC) protocols meet the 1988 Clinical
Laboratory Improvement Act mandates. Detailed QA/QC instructions are discussed
in the <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2017-2018/manuals/2017_MEC_Laboratory_Procedures_Manual.pdf">NHANES LPM</a>.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Mobile Examination
Centers (MECs) </b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Laboratory team
performance is monitored using several techniques. NCHS and contract
consultants use a structured competency assessment evaluation during visits to
evaluate both the quality of the laboratory work and the quality-control
procedures. Each laboratory staff member is observed for equipment operation,
specimen collection and preparation; testing procedures and constructive feedback
are given to each staff member. Formal retraining sessions are conducted
annually to ensure that required skill levels were maintained.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Analytical
Laboratories</b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">NHANES uses
several methods to monitor the quality of the analyses performed by the contract
laboratories. In the MEC, these methods include performing blind split samples
collected on &ldquo;dry run&rdquo; sessions. In addition, contract laboratories randomly
perform repeat testing on 2% of all specimens.</p><h2 id="Data_Processing_and_Editing">Data Processing and Editing</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The data were
reviewed. Incomplete data or improbable values were sent to the performing
laboratory for confirmation.</p><h2 id="Analytic_Notes">Analytic Notes</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Refer to the <a href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2017">2017-2018 Laboratory Data Overview</a> for general
information on NHANES laboratory data.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">There are over 800 laboratory tests performed on NHANES participants. However, not all participants provided biospecimens or enough volume for all the tests to be performed. The specimen availability can also vary by age or other population characteristics. For example, in 2017-2018, approximately 80% of children aged 1-17 years who were examined in the MEC provided a blood specimen through phlebotomy, while 95% of examined adults age 18 and older provided a blood specimen.&nbsp;Analysts should evaluate the extent of missing data in the dataset related to the outcome of interest as well as any predictor variables used in the analyses to determine whether additional re-weighting for item non-response is necessary. </p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Please refer to
the NHANES <a href="https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx" target="_blank">Analytic
Guidelines </a>and the on-line NHANES <a href="https://wwwn.cdc.gov/nchs/nhanes/tutorials/default.aspx">Tutorial </a>for further details on the use of sample weights and other analytic
issues.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><strong>Demographic and
Other Related Variables</strong></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The analysis of
NHANES laboratory data must be conducted using the appropriate survey design
and demographic variables. The <a href="https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Demographics&amp;CycleBeginYear=2017">NHANES 2017-2018
Demographics File</a> contains demographic data, health indicators, and
other related information collected during household interviews as well as the
sample design variables. The recommended procedure for variance estimation
requires use of stratum and PSU variables (SDMVSTRA and SDMVPSU, respectively)
in the demographic data file.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">This laboratory
data file can be linked to the other NHANES data files using the unique survey
participant identifier (i.e., SEQN).</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><strong style="mso-bidi-font-weight: normal;">The age range and constraints for Hepatitis B and D testing are as follows:</strong></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><strong>Hepatitis B</strong></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The hepatitis B
core antibody test is performed on all examined participants aged 6 years and
older while the hepatitis B surface antibody test is performed on all examined
participants aged 2 years old and older. The Hepatitis B surface antigen is
tested only when the Hepatitis B core antibody test is positive. Participant
results are coded positive for surface antigen if the surface antigen test is
positive; they are coded negative for surface antigen if the test for surface
antigen is negative or if the test for hepatitis B core antibody is negative.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><strong>Hepatitis D</strong></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The Hepatitis
Delta Virus (HDV) is a RNA defective virus; and an infection with HDV only
occurs in the presence of acute or chronic HBV infection. In NHANES, the test
for antibody to HDV is performed on all examined participants 6 years and older
who test positive or indeterminate for anti-HBc and HBsAg. The denominator for anti-HDV includes
all anti-HBc negative samples, the anti-HBc positive samples that were
subsequently found to be HBsAg negative, and the samples that were anti-HBc
positive and HBsAg positive that were subsequently found to be anti-HDV
negative.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><strong>Detection Limits</strong></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">This data is
qualitative. The use of lower limits of detection (LLODs) is not applicable.</p></div>
      <div id="Codebook">
        <h2>Codebook and Frequencies</h2>
        <div class="pagebreak">
          <h3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SEQN</dd>
            <dt>SAS Label: </dt>
            <dd>Respondent sequence number</dd>
            <dt>English Text: </dt>
            <dd class="info">Respondent sequence number</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXHBC">LBXHBC - Hepatitis B core antibody</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXHBC</dd>
            <dt>SAS Label: </dt>
            <dd>Hepatitis B core antibody</dd>
            <dt>English Text: </dt>
            <dd class="info">Hepatitis B core antibody</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Positive</td>
                <td class="values" align="right">407</td>
                <td class="values" align="right">407</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Negative</td>
                <td class="values" align="right">6386</td>
                <td class="values" align="right">6793</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">3</td>
                <td class="values">Indeterminate</td>
                <td class="values" align="right">1</td>
                <td class="values" align="right">6794</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">641</td>
                <td class="values" align="right">7435</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBDHBG">LBDHBG - Hepatitis B surface antigen</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDHBG</dd>
            <dt>SAS Label: </dt>
            <dd>Hepatitis B surface antigen</dd>
            <dt>English Text: </dt>
            <dd class="info">Hepatitis B surface antigen</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Positive</td>
                <td class="values" align="right">31</td>
                <td class="values" align="right">31</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Negative</td>
                <td class="values" align="right">375</td>
                <td class="values" align="right">406</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">3</td>
                <td class="values">Indeterminate</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">406</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">7029</td>
                <td class="values" align="right">7435</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBDHD">LBDHD - Hepatitis D antibody (anti-HDV)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDHD</dd>
            <dt>SAS Label: </dt>
            <dd>Hepatitis D antibody (anti-HDV)</dd>
            <dt>English Text: </dt>
            <dd class="info">Hepatitis D antibody (anti-HDV)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Positive</td>
                <td class="values" align="right">6</td>
                <td class="values" align="right">6</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Negative</td>
                <td class="values" align="right">399</td>
                <td class="values" align="right">405</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">3</td>
                <td class="values">Indeterminate</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">405</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">7030</td>
                <td class="values" align="right">7435</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    </div>
  </body>
</html>